US Broker Ratings

CRISPR Therapeutics AG (CRSP)

⚠️ No article content returned.

..

Bausch Health Companies Inc. (BHC) Stock Analysis: Evaluating a 45.75% Potential Upside

Bausch Health Companies Inc. (NYSE: BHC) stands as a noteworthy player in the healthcare sector, specifically within the niche of drug manufacturers specializing in both specialty..

Immunovant, Inc. (IMVT) Stock Analysis: Exploring a Promising 168.69% Potential Upside

Immunovant, Inc. (NASDAQ: IMVT), a bold player in the biotechnology sector, offers investors a unique opportunity to explore significant growth potential, particularly with a compelling 168.69%..

Certara, Inc. (CERT) Stock Analysis: Exploring a Potential 34% Upside in the Healthcare Information Services Sector

Certara, Inc. (NASDAQ: CERT), a prominent player in the healthcare information services industry, is catching the attention of investors with a potential upside of 34.05%. Headquartered..

Amedisys Inc (AMED) Stock Analysis: Exploring Growth Potential and Market Position in the Healthcare Sector

With a market cap of $3.09 billion, Amedisys Inc (NASDAQ: AMED) stands as a notable player in the U.S. healthcare sector, specifically within the medical care..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Uncovering a 140% Upside Potential in Precision Oncology

For investors with a keen interest in the biotechnology sector, IDEAYA Biosciences, Inc. (NASDAQ: IDYA) presents a compelling opportunity. The company, headquartered in South San Francisco,..

Kymera Therapeutics (KYMR) Stock Analysis: A Biotech Innovator with 32% Upside Potential

Kymera Therapeutics, Inc. (NASDAQ: KYMR) stands out as an intriguing candidate for investors seeking exposure to the dynamic biotech sector. With a market capitalization of $3.07..

Enovis Corporation (ENOV) Stock Analysis: Unveiling a 71.78% Potential Upside in the Medical Device Sector

Enovis Corporation (ENOV), a prominent player in the healthcare sector specializing in medical devices, presents an intriguing opportunity for investors seeking exposure to innovative healthcare solutions...

Organon & Co. (OGN) Stock Analysis: Uncovering a Potential 43% Upside Amidst Mixed Financial Signals

As Organon & Co. (NYSE: OGN) navigates the complex landscape of the healthcare sector, the stock currently trades at $9.76, significantly below its 52-week high of..

Denali Therapeutics Inc. (DNLI) Stock Analysis: A 119.78% Potential Upside in Neurodegenerative Therapy Innovations

For investors seeking exposure to the biotechnology sector, Denali Therapeutics Inc. (NASDAQ: DNLI) presents a captivating opportunity with its focus on tackling neurodegenerative and lysosomal storage..

Envista Holdings Corporation (NVST) Stock Analysis: Evaluating the Investment Landscape in Dental Instruments

Envista Holdings Corporation (NYSE: NVST), a prominent player in the healthcare sector, specifically in the medical instruments and supplies industry, presents a unique investment opportunity for..

QuidelOrtho Corporation (QDEL) Stock Analysis: Unveiling a 56% Potential Upside for Investors

QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the healthcare sector specializing in medical devices, has been capturing attention with its promising potential upside. Headquartered in..

Harmony Biosciences Holdings (HRMY): Investor Outlook Reveals 45% Potential Upside Amid Robust Pipeline

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), a dynamic player in the healthcare sector, continues to capture investor interest. Specializing in biotechnology, the company focuses on developing..

NovoCure Limited (NVCR) Stock Analysis: Unpacking a Staggering 92.73% Potential Upside

For investors with a keen interest in the healthcare sector, NovoCure Limited (NASDAQ: NVCR) presents a compelling case study of innovation intersecting with the complexities of..

DENTSPLY SIRONA Inc. (XRAY): Investor Outlook with a 11.82% Potential Upside

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) is a renowned name in the healthcare sector, specifically in the realm of medical instruments and supplies, with a rich history..

Catalyst Pharmaceuticals, Inc. (CPRX)

⚠️ No article content returned.

..

Premier, Inc. (PINC) Stock Analysis: Exploring the Healthcare Innovator’s Stability Amidst Challenges

Premier, Inc. (NASDAQ: PINC), a key player in the healthcare sector, is making waves with its dual-segment approach in Supply Chain Services and Performance Services. Headquartered..

Progyny, Inc. (PGNY) Stock Analysis: A 19.48% Potential Upside in the Healthcare Sector

Progyny, Inc. (NASDAQ: PGNY), a prominent player in the healthcare plans industry, presents an intriguing investment opportunity with a potential upside of 19.48% based on current..

Ultragenyx Pharmaceutical Inc. (RARE)

⚠️ No article content returned.

..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Exploring a 53.68% Potential Upside for Investors

Alphatec Holdings, Inc. (NASDAQ: ATEC), a prominent player in the medical devices sector, is gaining attention from investors due to its promising growth trajectory and innovative..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds